METROSIN XL AM 50 TABLET

Product Description

METROSIN XL AM 50 TABLET Dual Action Extended-Release Therapy for Comprehensive Blood Pressure ControlMETROSIN XL AM 50 TABLET combines Metoprolol Succinate 47.5 mg (equivalent to Metoprolol Tartrate ER 50 mg) with Amlodipine Besylate (equivalent to Amlodipine 5 mg), offering a powerful once-daily treatment for hypertension and cardiovascular risk reduction. This combination of a beta-blocker and calcium channel blocker provides synergistic blood pressure control and heart protection.Key Benefits: Dual mechanism for more effective blood pressure management Metoprolol (ER) helps lower heart rate and blood pressure with long-lasting control Amlodipine relaxes blood vessels, reducing vascular resistance and chest pain Reduces the risk of heart attack, stroke, and other cardiovascular complications Ideal for patients requiring combination therapy for hypertension or angina Recommended Usage: Formulated for patients with moderate to severe hypertension, stable angina, and post-cardiac event care. Preferred by cardiologists and general practitioners for its once-daily convenience and therapeutic effectiveness.Why Choose METROSIN XL AM 50?Manufactured with high-quality standards, METROSIN XL AM 50 is a clinically trusted cardiovascular solution for long-term therapy. An essential addition for pharma distributors, hospital procurement teams, and bulk medicine buyers looking to offer high-demand chronic care medications. Strengthen your product portfolio with METROSIN XL AM 50 TABLET a reliable, dual-action solution for modern heart health management. Contact us today for bulk orders and distribution opportunities.